Summary: A glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (From Martindale, The Extra Pharmacopoeia, 30th ed, p739)

Top Publications

  1. Kaderli B, Avci R, Yucel A, Guler K, Gelisken O. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2007;27:164-8 pubmed
    ..Because intravitreal triamcinolone (IVTA) has shown promise in improving edematous retinal disorders, a pilot trial of this therapy in NAION was ..
  2. Davison S, Dayan J, Clemens M, Sonni S, Wang A, Crane A. Efficacy of intralesional 5-fluorouracil and triamcinolone in the treatment of keloids. Aesthet Surg J. 2009;29:40-6 pubmed publisher
    ..Differences in complication rates were not statistically significant. Combination 5-FU/triamcinolone is superior to intralesional steroid therapy in the treatment of keloids.
  3. Ekdawi N, Bakri S. Intravitreal triamcinolone and bevacizumab combination therapy for macular edema due to central retinal vein occlusion refractory to either treatment alone. Eye (Lond). 2007;21:1128-30 pubmed
  4. Cote D, Wright E. Triamcinolone-impregnated nasal dressing following endoscopic sinus surgery: a randomized, double-blind, placebo-controlled study. Laryngoscope. 2010;120:1269-73 pubmed publisher
    ..with polyposis who were to undergo bilateral endoscopic sinus surgery were recruited and randomized to receive triamcinolone-impregnated bioresorbable dressing (Nasopore; Stryker Canada, Hamilton, Ontario, Canada) in one nasal cavity ..
  5. Lim J, Na K. A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision. Indian J Ophthalmol. 2011;59:93-6 pubmed publisher
    To compare the effect of intravitreal bevacizumab and triamcinolone in patients with macular edema after central retinal vein occlusion (CRVO), presenting with poor visual acuity.
  6. Blanco C, Fagúndez A, Buznego L, López Moya J. [Leak of intravitreal triamcinolone to the anterior chamber]. Arch Soc Esp Oftalmol. 2007;82:781-3 pubmed
    A 78-year-old man with phakic eyes underwent photodynamic therapy followed by intravitreal injection of triamcinolone. During the injection a white solution was observed in the anterior chamber...
  7. Kim Y, Chung I, Choi M, Kim Y, Lee J, Park C, et al. Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia. Neurobiol Dis. 2007;26:569-76 pubmed
    We examined the effect of triamcinolone acetonide (TA), a corticosteroid, on the relationship between vascular pathophysiology and vascular endothelial growth factor (VEGF) activation in the retina of a rat model of oxygen-induced ..
  8. Qiao J, Kontoyiannis D, Calderone R, Li D, Ma Y, Wan Z, et al. Afyap1, encoding a bZip transcriptional factor of Aspergillus fumigatus, contributes to oxidative stress response but is not essential to the virulence of this pathogen in mice immunosuppressed by cyclophosphamide and triamcinolone. Med Mycol. 2008;46:773-82 pubmed publisher
    ..fumigatus strain in a murine model of invasive pulmonary aspergillosis. Taken together, these results demonstrate that Afyap1 is involved in oxidative stress response but is not an essential virulence factor for A. fumigatus...
  9. Moon J, Kuh S, Park H, Kim K, Park J, Chin D, et al. Triamcinolone decreases bupivacaine toxicity to intervertebral disc cell in vitro. Spine J. 2012;12:665-73 pubmed publisher
    ..Considering the frequent use of these agents in spinal interventions, it is meaningful to know how they affect intervertebral disc cells...

More Information


  1. Ramanathan R, Pau A, Busse K, Zemskova M, Nieman L, Kwan R, et al. Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. Clin Infect Dis. 2008;47:e97-9 pubmed publisher
    ..therapy, which included ritonavir, who developed Cushing syndrome with profound complications after epidural triamcinolone injections...
  2. Hernández Da Mota S, Chacón Lara A, Hernández Vázquez E. [Use of triamcinolone and bevacizumab in 25G phaco-vitrectomy surgery for the treatment of cataract and diabetic macular edema]. Arch Soc Esp Oftalmol. 2008;83:293-300 pubmed
    To evaluate the safety and efficacy of combined phacoemulsification and triamcinolone-assisted vitrectomy with intravitreal injection of bevacizumab in patients with cataract and diffuse diabetic macular edema...
  3. Hosseini J, Kaviani A, Golshan A. Clean intermittent catheterization with triamcinolone ointment following internal urethrotomy. Urol J. 2008;5:265-8 pubmed
    Our aim was to evaluate clean intermittent catheterization (CIC) results in combination with triamcinolone ointment for lubrication of the catheter after internal urethrotomy...
  4. Veckeneer M, Wong D. Visualising vitreous through modified trans-scleral illumination by maximising the Tyndall effect. Br J Ophthalmol. 2009;93:268-70 pubmed publisher
    ..Perfluorocarbon liquid (PFCL) is used to confine the aqueous environment to the anterior vitreous cavity and triamcinolone is added to increase light scatter...
  5. Kramar M, Vu L, Whitson J, He Y. The effect of intravitreal triamcinolone on intraocular pressure. Curr Med Res Opin. 2007;23:1253-8 pubmed
    To evaluate the effect of triamcinolone acetonide (ITA) on intraocular pressure (IOP) following intravitreal injection, and, in those patients who experience post-injection elevation of IOP, to determine the time course, effect of ..
  6. Bearelly S, Cooney M, Stinnett S, Fekrat S. Intravitreal triamcinolone for cystoid macular edema related to branch retinal vein occlusion. Ann Ophthalmol (Skokie). 2006;38:317-20 pubmed
    We retrospectively evaluated the effectiveness of intravitreal triamcinolone in treating 19 eyes with macular edema related to branch retinal vein occlusion (BRVO)...
  7. Ring D, Lozano Calderon S, Shin R, Bastian P, Mudgal C, Jupiter J. A prospective randomized controlled trial of injection of dexamethasone versus triamcinolone for idiopathic trigger finger. J Hand Surg Am. 2008;33:516-22; discussion 523-4 pubmed publisher resolution of triggering 3 months after injection with either a soluble (dexamethasone) or insoluble (triamcinolone) corticosteroid for idiopathic trigger finger...
  8. Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol. 2009;34:219-23 pubmed publisher
    ..Patients in group 1 were given intralesional triamcinolone acetonide (TAC), and patients in group 2 were given a combination of TAC and 5-fluorouracil (5-FU); both ..
  9. Bergstrom C, Hubbard G. Combination intravitreal triamcinolone injection and cryotherapy for exudative retinal detachments in severe Coats disease. Retina. 2008;28:S33-7 pubmed publisher
    Intravitreal triamcinolone injection effectively reduces subretinal fluid in pediatric patients with exudative retinal detachments in severe Coats disease...
  10. Khurieva Sattler E, Krause M, Löw U, Gatzioufas Z, Toropygin S, Seitz B, et al. [Comparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular oedema]. Klin Monbl Augenheilkd. 2010;227:496-500 pubmed publisher
    ..DDME) were evaluated after vitrectomy with internal limiting membrane (ILM) peeling versus intravitreal triamcinolone acetonide (TA)...
  11. Tempfer H, Gehwolf R, Lehner C, Wagner A, Mtsariashvili M, Bauer H, et al. Effects of crystalline glucocorticoid triamcinolone acetonide on cultered human supraspinatus tendon cells. Acta Orthop. 2009;80:357-62 pubmed publisher
    ..and measurement of 3H-thymidine uptake we investigated the effects of the crystalline glucocorticoid triamcinolone acetonide (TAA) when added to the culture medium of isolated human rotator cuff tendon cells...
  12. Zacharias L, Estrago Franco M, Ramirez C, Kenney M, Takahashi W, Seigel G, et al. The effects of commercially available preservative-free FDA-approved triamcinolone (Triesence®) on retinal cells in culture. J Ocul Pharmacol Ther. 2011;27:143-50 pubmed publisher
    To evaluate the effects of Triesence® (TRI), a new preservative-free triamcinolone approved by the U.S...
  13. Hashimoto S, Kobayashi M, Takeuchi M, Sato Y, Narisawa R, Aoyagi Y. The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc. 2011;74:1389-93 pubmed publisher
  14. Sharma N, Mehta K, Mahajan V, Kanga A, Sharma V, Tegta G. Cutaneous sporotrichosis of face: polymorphism and reactivation after intralesional triamcinolone. Indian J Dermatol Venereol Leprol. 2007;73:188-90 pubmed
    ..The patient had reactivation of infection following an infiltration of the scar with triamcinolone acetonide injection. Various other aspects of these unusual phenomena are also discussed.
  15. Jaissle G, Bartz Schmidt K, Szurman P. [Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling]. Ophthalmologe. 2008;105:575-7 pubmed
    Although current in vitro studies show local cytotoxicity of triamcinolone (TA) crystals if they are in direct contact with cells, a toxic effect of epiretinal TA deposits has not been reported yet clinically...
  16. Syed H, Green L, Bianski B, Jobe C, Wongworawat M. Bupivacaine and triamcinolone may be toxic to human chondrocytes: a pilot study. Clin Orthop Relat Res. 2011;469:2941-7 pubmed publisher
    ..Given the frequency of use of these agents, it is important to know whether they are in fact toxic...
  17. Suen W, Chau Y. Specific uptake of folate-decorated triamcinolone-encapsulating nanoparticles by retinal pigment epithelium cells enhances and prolongs antiangiogenic activity. J Control Release. 2013;167:21-8 pubmed publisher
    ..b>Triamcinolone acetonide (TA) was efficiently encapsulated (>97%) into the folate-decorated nanoparticles and was slowly ..
  18. Forte R, Cennamo G, Finelli M, Farese E, D Amico G, Nicoletti G, et al. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema. Eye (Lond). 2010;24:1325-30 pubmed publisher
    ..diabetic macular oedema (DME) treated with intravitreal bevacizumab (IVB) or with intravitreal injection of triamcinolone combined with macular laser grid (IVTA-MLG) from September 2005 to February 2008...
  19. Kreutzer T, Al Saeidi R, Kook D, Wolf A, Ulbig M, Neubauer A, et al. Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema. Ophthalmologica. 2010;224:258-64 pubmed publisher
    Our purpose was to compare the effect of triamcinolone and bevacizumab (Avastin) on the retinal thickness and functional outcome in patients with diabetic macular edema. A collective of 32 patients, who had been treated by a single 4...
  20. LeFevre C, Hoffstetter S, Meyer S, Gavard J. Management of lichen sclerosus with triamcinolone ointment: effectiveness in reduction of patient symptom scores. J Low Genit Tract Dis. 2011;15:205-9 pubmed publisher
    To determine whether topical triamcinolone ointment effectively reduces patient's symptoms for the management of lichen sclerosus (LS).
  21. Lai C, Wang N, Wu W, Yeung L, Hwang Y, Chen K, et al. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane. Cutan Ocul Toxicol. 2011;30:292-7 pubmed publisher
    To compare the long-term anatomical and visual outcomes of patients with idiopathic epiretinal membrane (ERM) removed by vitrectomy and membrane peeling with or without the use of intravitreal injection of triamcinolone acetonide (IVTA).
  22. Gillies M, Islam F, Zhu M, Larsson J, Wong T. Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. Br J Ophthalmol. 2007;91:1323-6 pubmed
    The efficacy and safety of repeated injections of intravitreal triamcinolone (IVTA) for diabetic macular oedema is unclear, with results of previous reports conflicting...
  23. Gibran S, Khan K, Jungkim S, Cleary P. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema. Ophthalmology. 2007;114:890-4 pubmed
    ..of visual outcome in patients with diabetic macular edema (DME) who underwent a single dose of intravitreal triamcinolone. Retrospective case analysis with prospective data collection for controls. Ninety-three cases and 25 controls...
  24. Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, et al. Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study. Br J Ophthalmol. 2008;92:356-60 pubmed publisher
    ..of intravitreal bevacizumab (Avastin) and verteporfin (photodynamic) therapy (PDT) combined with intravitreal triamcinolone (IVTA) in patients with neovascular age-related macular degeneration (AMD)...
  25. Taghizadeh R, Shoaib T, Hart A, Weiler Mithoff E. Triamcinolone reduces seroma re-accumulation in the extended latissimus dorsi donor site. J Plast Reconstr Aesthet Surg. 2008;61:636-42 pubmed
    ..We designed a double-blind randomised controlled trial to test the hypothesis that an intracavity injection of the anti-inflammatory corticosteroid triamcinolone would inhibit seroma re-accumulation.
  26. Ashkenazi A, Matro R, Shaw J, Abbas M, Silberstein S. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study. J Neurol Neurosurg Psychiatry. 2008;79:415-7 pubmed
    To determine whether adding triamcinolone to local anaesthetics increased the efficacy of greater occipital nerve block (GONB) and trigger-point injections (TPIs) for transformed migraine (TM)...
  27. Hahn R, Sacu S, Michels S, Varga A, Weigert G, Geitzenauer W, et al. [Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration]. Ophthalmologe. 2007;104:588-93 pubmed
    ..was to compare intravitreal bevacizumab (IVB) and verteporfin therapy in combination with 4 mg intravitreal triamcinolone (PDT-IVTA) in patients with neovascular age-related macular degeneration (AMD)...
  28. Othman I, Moussa M, Bouhaimed M. Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications. Br J Ophthalmol. 2010;94:606-10 pubmed publisher
    AIM To evaluate the role of intravitreal Triamcinolone (TA) in the early management of Coats disease. METHODS Retrospective, interventional case series. RESULTS 15 consecutive cases with Coats disease were managed with 4 mg/0...
  29. Hørslev Petersen K, Hetland M, Junker P, Pødenphant J, Ellingsen T, Ahlquist P, et al. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-b. Ann Rheum Dis. 2014;73:654-61 pubmed publisher
    ..protocol (Clinical Trials:NCT00660647) studied whether adalimumab added to methotrexate and intra-articular triamcinolone as first-line treatment in early rheumatoid arthritis (ERA) increased the frequency of low disease activity (..
  30. Kwon S, Kim Y, Bang Y, Lee J, Park I. Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion. J Ocul Pharmacol Ther. 2013;29:5-9 pubmed publisher
    ..secondary to branch retinal vein occlusion (BRVO) and to compare the visual outcome and macular thickness with eyes treated with intravitreal injection of triamcinolone acetonide (IVTA) and intravitreal injection of bevacizumab (IVB).
  31. Virgili G, Parravano M, Menchini F, Brunetti M. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. Cochrane Database Syst Rev. 2012;12:CD007419 pubmed publisher
    ..Safety of both drug and the intravitreal injection procedure were good in the trials, but further long-term data are needed to exclude small, but clinically important differences regarding systemic adverse events. ..
  32. César I, Byrro R, de Santana E Silva Cardoso F, Mundim I, de Souza Teixeira L, de Sousa W, et al. Determination of triamcinolone in human plasma by a sensitive HPLC-ESI-MS/MS method: application for a pharmacokinetic study using nasal spray formulation. J Mass Spectrom. 2011;46:320-6 pubmed publisher
    ..ionization tandem mass spectrometry (HPLC-ESI-MS/MS) method for the quantitation of triamcinolone in human plasma after nasal spray application was developed and validated...
  33. Martires K, Domingo D, Hsia A, Fu P, Cooper K, Baron E. Effects of pimecrolimus versus triamcinolone on Langerhans cells after UV exposure. Exp Dermatol. 2011;20:280-2 pubmed publisher
    ..A RCT was conducted investigating pimecrolimus 1% cream vs triamcinolone 0.1% cream on UV-irradiated epidermal LC on 20 healthy volunteers...
  34. Rouvas A, Papakostas T, Vavvas D, Vergados I, Moschos M, Kotsolis A, et al. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina. 2009;29:536-44 pubmed publisher
    ..1) intravitreal ranibizumab, 2) intravitreal ranibizumab plus photodynamic therapy (PDT), and 3) intravitreal triamcinolone plus PDT in retinal angiomatous proliferation...
  35. Sacu S, Michels S, Prager F, Weigert G, Dunavoelgyi R, Geitzenauer W, et al. Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results. Eye (Lond). 2009;23:2223-7 pubmed publisher
    ..functional and anatomic outcomes of intravitreal bevacizumab (IVB) and photodynamic therapy plus intravitreal triamcinolone (PDT+IVTA) combination in patients with neovascular age-related macular degeneration (AMD)...
  36. Cakir M, Cekic O, Yilmaz O. Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease. J AAPOS. 2009;13:94-6 pubmed publisher
    ..associated with Best disease responded well to a single intravitreal injection of combined bevacizumab and triamcinolone acetonide...
  37. Brinks A, van Rijn R, Bohnen A, Slee G, Verhaar J, Koes B, et al. Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice. BMC Musculoskelet Disord. 2007;8:95 pubmed
    ..A distinction between placebo effect of the injection and specific effects of the corticosteroids is therefore not possible. ..
  38. Ahmadieh H, Taei R, Soheilian M, Riazi Esfahani M, Karkhaneh R, Lashay A, et al. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration. BMC Ophthalmol. 2007;7:10 pubmed
    ..consisting of single-session photodynamic therapy (PDT), intravitreal bevacizumab (IVB) and intravitreal triamcinolone (IVT) as initial pulse therapy followed by repeat intravitreal bevacizumab injections for maintenance ..
  39. Marticorena J, Gomez Ulla F, Romano M, Luna I. Repeated pseudoendophthalmitis after combined photodynamic therapy and intravitreal triamcinolone. Graefes Arch Clin Exp Ophthalmol. 2007;245:1403-4 pubmed
  40. Yip P, Woo C, Tang H, Ho C. Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone. Br J Ophthalmol. 2009;93:754-8 pubmed publisher
    ..therapy consisting single-session photodynamic therapy (PDT), intravitreal bevacizumab (IVB) and intravitreal triamcinolone (IVTA) for treatment of neovascular age-related macular degeneration (AMD) METHODS: Consecutive patients with ..
  41. Coombes B, Bisset L, Connelly L, Brooks P, Vicenzino B. Optimising corticosteroid injection for lateral epicondylalgia with the addition of physiotherapy: a protocol for a randomised control trial with placebo comparison. BMC Musculoskelet Disord. 2009;10:76 pubmed publisher
    ..Australian New Zealand Clinical Trials Register ACTRN12609000051246. ..
  42. Hayreh S. Intravitreal triamcinolone for nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2008;28:77-8; author reply 78-9 pubmed publisher
  43. Kelman S. Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: do they merit further study?. J Neuroophthalmol. 2007;27:161-3 pubmed
  44. Verma L, Vivek M, Kumar A, Tewari H, Venkatesh P. A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema. J Ocul Pharmacol Ther. 2004;20:277-84 pubmed
    The aim of the present prospective controlled trial was to evaluate the adjuvant role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema (DDME)...
  45. Mignogna M, Fedele S, Lo Russo L, Adamo D, Satriano R. Effectiveness of small-volume, intralesional, delayed-release triamcinolone injections in orofacial granulomatosis: a pilot study. J Am Acad Dermatol. 2004;51:265-8 pubmed
    ..Treatment with high-volume triamcinolone injections has been shown to be effective but requires nerve block anesthesia and causes a dramatic temporary ..
  46. Chiba H, Akita H, Hui S, Takahashi Y, Nagasaka H, Fuda H, et al. Effects of triamcinolone on brain and cerebrospinal fluid apolipoprotein E levels in rats. Life Sci. 1997;60:1757-61 pubmed
    The effects of the short term administration of triamcinolone (0...
  47. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol. 2001;29:2-6 pubmed
    To report the safety and efficacy of intravitreal triamcinolone in the treatment of inflammatory cystoid macular oedema (CMO) in six patients who were resistant to other forms of therapy...
  48. Eichenhorn M, Wise R, Madhok T, Gerald L, Bailey W, Tashkin D, et al. Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II. Chest. 2003;124:57-62 pubmed
    ..from the 1,116 patients already enrolled in Lung Health Study II and were randomized to receive either triamcinolone, 1,200 microg, or placebo daily...
  49. Chan C, Fan D, Chan W, Lai W, Lee V, Lam D. Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study. Eye (Lond). 2005;19:625-30 pubmed
    ..IOP) and corneal endothelial changes, over a 6-month period, after a single injection of intravitreal triamcinolone (ivTA) in Chinese patients...
  50. Scanlon P, Connett J, Wise R, Tashkin D, Madhok T, Skeans M, et al. Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med. 2004;170:1302-9 pubmed
    ..They used inhaled triamcinolone acetonide, 600 mcg, or placebo, twice daily...
  51. Hirooka K, Shiraga F, Tanaka S, Baba T, Mandai H. Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone. Jpn J Ophthalmol. 2006;50:235-8 pubmed
    ..factors that induce an elevation of intraocular pressure (IOP) after trans-Tenon retrobulbar injections of triamcinolone acetonide...
  52. Cordray S, Harjo J, Miner L. Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear Nose Throat J. 2005;84:426-30 pubmed
    ..placebo-controlled comparison of intranasal hypertonic Dead Sea saline spray and intranasal aqueous triamcinolone spray in 15 patients with seasonal allergic rhinitis. Results were based on a 7-day regimen...
  53. Ricciardi A, Ruberto A, García Hernández M, Kotzalidis G, Trevisi M, Persechino S, et al. Alopecia areata with comorbid depression: early resolution with combined paroxetine-triamcinolone treatment. J Eur Acad Dermatol Venereol. 2006;20:1000-1 pubmed